Julian Minett, CEO of Spencer Group is looking forward to attending this year’s Outsourcing Clinical Trials and Clinical Trials Supply Event in Copenhagen, 25th – 26th October.
As an award winning, specialist boutique in the commercial education sector for over 15 years, Spencer Group has seen significant shifts in the education talent landscape over the last 24 months…
Spencer Group were delighted to attend the 17th edition of the Scrip Awards on the 2nd December, hosted live in London. The Scrip Awards honours the outstanding accomplishments of those improving human healthcare worldwide…
For the third year in a row Spencer Group were proud to attend the EducationInvestor Awards at the Royal Lancaster, London on the 30th November, as award finalists for the Recruitment Services category. Aimed at consultants in…
Julian Minett speaks with Rowan Bell, Senior HR Director at Wellington College China, and Chris Marshall, Founding Partner of School Business Solutions, about the launch of their HR support network, ISCHR, within the K12 arena.
In today’s podcast we are discussing the current challenges regarding A Level results and the future of higher education with Carl Lygo, current CEO and Vice Chancellor of Arden University.
Today we are joined by Allan Fisher, Senior Director, Academics at Emeritus, for the next episode in our Covid series.
We are excited to be speaking to Steve Geffon, a highly experienced commercial lead in the eclinical and services market. Steve is the CCO of Science37, an organisation with over 6 years in virtual/decentralised trials.
Steve Kent is currently Non-Executive Chairman at Phlexglobal, 4ways and Pharmaspectra, as well as Non-Executive Director at Imagen Therapeutics. During Steve’s time as an executive
Steve Powell is a renowned, international expert with a career spanning over 30 years within pharmaceutical technology. He has worked for organisations such as GSK and Phase Forward and now has a number of NED and Chair positions